- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02900326
Mindfulness-based Stress Reduction (MBSR) Program Combined With Endurance Exercise Training: a Help in Treatment for Breast Cancer (MBSR)
May 17, 2022 updated by: University Hospital, Strasbourg, France
Effect of a Mindfulness-based Stress Reduction (MBSR) Program Combined With Endurance Exercise Training: a Help to Improve Exercise Capacity and Quality of Life in Breast Cancer
Integrative approaches to promote wellness and reduce the distress associated with cancer are considered as essential components of cancer care.
In case, exercise training has been shown to produce many positive physiological and psychological benefits.
Mindfulness-based stress reduction program shows similar beneficial effects, and especially in emotional distress management.
The aim of the study is to examine the cumulative effect of an 8 week-exercise-training program combined with an MBSR program on cardio-respiratory fitness and quality of life in women with breast cancer.
These effects are thought to be mediated in part through changes in underlying brain processes, that investigators will be put in light.
Through telomerase activity, oxidative stress, mitochondrial respiration and blood cytokine level measurements, investigators could expect to better understand the effect of these combined training in breast cancer.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Strasbourg, France, 67091
- Physiologie et EFR/ EA 3072 mitochondrie, stress oxydant et protection musculaire
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Breast cancer
- Having completed the chemotherapy period
- Undergoing radiotherapy and/or hormono therapy
Exclusion Criteria:
- Regular physical activity higher than 4 hours per week.
- Any disease cardiac, respiratory, neurological or articular disease, which counteract the muscular training )
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control patients with no intervention
group without intervention
|
|
Experimental: Endurance training program (8 weeks) group
only physical training group
|
In each group, there will be a comparison of aerobic capacity, quality of life (with questionnaires), functional cerebral measurements (fRMI), and telomerase activity between before and after the 8 weeks program
|
Experimental: MBSR group (mindfulness-based-stress-reduction)
only mental training group (8 weeks)
|
|
Experimental: Endurance training program combined with MBSR sessions
Endurance training program combined with MBSR sessions, during 8 weeks (mindfulness-based-stress-reduction)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evolution of V02 max between inclusion and 8 weeks
Time Frame: 8 weeks
|
effect of physical training associated with mental work on physical abilities of patients
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: LONSDORFER Evelyne, Hôpitaux Universitaires de Strasbourg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 12, 2015
Primary Completion (Actual)
May 12, 2015
Study Completion (Actual)
March 30, 2021
Study Registration Dates
First Submitted
June 16, 2015
First Submitted That Met QC Criteria
September 13, 2016
First Posted (Estimate)
September 14, 2016
Study Record Updates
Last Update Posted (Actual)
May 25, 2022
Last Update Submitted That Met QC Criteria
May 17, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5970
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
Clinical Trials on Vo2max measurements
-
Centre d'Etudes et de Recherche pour l'Intensification...European Association for the Study of DiabetesCompletedType 1 Diabetes With a Subcutaneous Insulin Pump | Adjustment of the Recommended Basal Insulin Flow Rate in the Event of Physical Activity | Adjustment of the Recommended Prandial Insulin in the Event of Physical ActivityFrance
-
Rigshospitalet, DenmarkRecruiting
-
University of CopenhagenVentriJect ApSCompletedCardiorespiratory Fitness TestDenmark
-
Lancaster UniversityCompletedType 2 DiabetesUnited Kingdom
-
Hacettepe UniversityNot yet recruitingHealthy | Breast Cancer | Oxygen Consumption | Upper ExtremityTurkey
-
Sheba Medical CenterBar-Ilan University, IsraelUnknown
-
Lindenwood UniversityIncrenovo, LLCCompletedLactate Blood Increase | Exhaustion - PhysiologicalUnited States
-
University Health Network, TorontoRecruitingRespiratory Insufficiency | Lung Injury | Mechanical Ventilation Complication | Diaphragm Injury | Abdominal Muscle StrainedCanada
-
Marmara UniversityRecruitingCerebral Palsy | Infant, Premature, Diseases | Preterm Birth ComplicationTurkey
-
Kahramanmaras Sutcu Imam UniversityCompletedCerebral Palsy | Infant, Premature, Diseases | Neurologic Disorder | Infant, Newborn, Disease | Infant Development | Development Delay | Infant, Very Low Birth Weight | Infant, Small for Gestational Age | Infant AsphyxiaTurkey